Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer
Clinical trial NCT00451555 · COMPLETED
Trial details
- NCT number
- NCT00451555
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-11
- Primary completion
- 2010-12-28
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.